Brawn Biotech quarterly results and financials

Brawn Biotech (BSE 530207)₹21.90+4.04%(9 Nov 2026 close)Pharmaceuticals

Key facts

In the Mar 2026 quarter (standalone), Brawn Biotech reported sales of ₹1.97 Cr, down 12.4% from Mar 2025, and net profit of ₹0.59 Cr. For the year to Mar 2026, sales were ₹16.94 Cr and net profit ₹0.95 Cr.

Sales (Mar 2026): ₹1.97 Cr
Net profit (Mar 2026): ₹0.59 Cr
Sales (FY Mar 2026): ₹16.94 Cr
Net profit (FY Mar 2026): ₹0.95 Cr
EPS (Mar 2026): ₹1.94
Borrowings (Mar 2026): ₹0 Cr

Company filings, standalone accounts; latest reported quarter Mar 2026

Brawn Biotech quarterly results

₹ crore unless stated; each column is a quarter.

Brawn Biotech Quarterly results
	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Sales	7.27	2.91	2.83	3.44	4.05	3.29	3.83	2.25	5.79	4.88	4.30	1.97
Expenses	7.47	3.32	3.43	3.85	4.57	3.63	4.25	2.82	5.64	4.89	4.33	2.50
Operating Profit	−0.17	−0.40	−0.59	−0.40	−0.51	−0.33	−0.41	−0.56	0.19	0.02	−0.02	−0.52
OPM %	−2.2%	−13.4%	−20.4%	−11.3%	−12.3%	−9.7%	−10.4%	−24.3%	3.1%	0.2%	−0.2%	−25.7%
Other Income	0.00	0.00	0.00	0.09	0.00	0.00	0.00	0.08	0.08	0.08	0.08	0.17
Interest	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Depreciation	0.03	0.04	0.04	0.04	0.04	0.04	0.04	0.04	0.04	0.04	0.04	0.04
Profit before tax	−0.17	−0.41	−0.60	−0.33	−0.52	−0.34	−0.42	−0.48	0.23	0.06	0.04	−0.35
Tax %	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	−261.0%
Net Profit	−0.18	−0.43	−0.62	−0.35	−0.54	−0.33	−0.44	−0.50	0.25	0.08	0.06	0.59
EPS (Rs)	−0.58	−1.41	−2.04	−1.14	−1.78	−1.14	−1.44	−1.64	0.81	0.24	0.18	1.94

Brawn Biotech profit and loss

₹ crore unless stated; years end in March. TTM is the last four quarters.

Brawn Biotech Profit and loss
	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	46.78	59.67	55.59	65.09	49.52	34.93	8.52	22.17	16.46	13.43	16.94	16.94
Expenses	45.56	58.74	53.92	64.20	49.01	35.70	10.56	22.58	18.01	15.28	17.35	17.36
Operating Profit	1.45	1.26	1.97	1.18	0.74	−0.61	−2.01	−0.31	−1.47	−1.78	−0.34	−0.33
OPM %	3.1%	2.1%	3.5%	1.8%	1.5%	−1.7%	−23.4%	−1.3%	−8.9%	−13.1%	−1.9%	−2.0%
Other Income	0.00	0.62	0.08	0.75	0.18	0.30	0.00	0.02	0.09	0.08	0.44	0.41
Interest	0.12	0.08	0.07	0.08	0.06	0.05	0.07	0.02	0.07	0.00	0.00	0.00
Depreciation	0.04	0.04	0.04	0.04	0.04	0.04	0.06	0.12	0.11	0.12	0.13	0.16
Profit before tax	1.30	1.75	1.97	1.80	0.81	−0.35	−2.10	−0.40	−1.53	−1.78	0.00	−0.02
Tax %	27.5%	20.5%	34.8%	26.6%	28.1%	55.7%	−22.2%	109.9%	−19.4%	−3.3%	—	—
Exceptional items	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—
Net Profit	0.96	1.38	1.27	1.34	0.60	−0.54	−1.63	−0.88	−1.26	−1.75	0.95	0.98
EPS (Rs)	3.18	4.65	4.29	4.44	1.98	−1.84	−5.49	−2.91	−4.19	−5.82	3.14	3.17
Dividend payout %	31.5%	32.3%	23.4%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—

Brawn Biotech balance sheet

₹ crore, at each year end.

Brawn Biotech Balance sheet
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	2.99	3.00	2.99	3.00	3.01	3.00	2.99	3.00	3.00	3.01	3.01	3.00
Reserves	1.93	2.53	3.91	4.63	5.67	6.27	5.78	4.23	3.30	2.07	0.37	1.34
Borrowings	0.11	0.13	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Liabilities	8.91	8.26	10.07	14.87	13.78	10.98	5.06	6.53	8.18	9.48	17.07	16.44
Total Liabilities	13.94	13.92	16.97	22.50	22.46	20.25	13.83	13.76	14.48	14.56	20.45	20.78
Fixed Assets	0.18	0.25	0.24	0.21	0.20	0.19	0.15	0.40	0.36	0.34	0.47	0.35
CWIP	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.02	0.02	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Assets	13.74	13.65	16.73	22.29	22.26	20.06	13.68	13.36	14.12	14.22	19.98	20.43
Inventories	1.04	0.51	0.38	0.36	0.35	0.40	0.27	4.73	4.80	6.03	10.49	10.08
Trade receivables	9.19	9.18	12.98	15.01	16.43	14.96	9.26	2.80	5.31	3.87	3.40	3.54
Cash & equivalents	0.26	0.16	1.99	0.41	0.53	0.39	0.39	0.23	0.45	0.39	0.21	0.29
Total Assets	13.94	13.92	16.97	22.50	22.46	20.25	13.83	13.76	14.48	14.56	20.45	20.78

Brawn Biotech cash flow

₹ crore, for each year.

Brawn Biotech Cash flow
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from operating activity	0.22	0.04	1.36	−1.53	0.20	−0.07	0.02	0.18	0.31	−0.02	0.04	0.10
Cash from investing activity	−0.13	−0.09	0.58	0.00	0.00	−0.03	0.00	−0.31	−0.11	−0.02	−0.25	−0.04
Cash from financing activity	0.00	−0.06	−0.12	−0.07	−0.07	−0.06	−0.05	−0.07	−0.02	0.00	0.00	0.00
Net cash flow	0.12	−0.09	1.84	−1.61	0.16	−0.15	0.00	−0.18	0.22	−0.05	−0.21	0.09
Capex	0.11	0.07	0.02	0.00	0.00	0.01	0.00	0.29	0.09	0.00	0.23	0.02
Free cash flow	0.10	−0.02	1.33	−1.53	0.20	−0.09	0.02	−0.10	0.21	−0.03	−0.18	0.07
CFO / OP %	41.0%	28.0%	170.0%	−14.0%	88.0%	21.0%	−52.0%	−10.0%	−103.0%	2.0%	−3.0%	−33.0%

Brawn Biotech ratios

Working-capital days and returns, by year.

Brawn Biotech Ratios
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor days	88	73	80	100	93	111	98	121	88	87	93	77
Inventory days	10	4	2	2	1	2	2	261	90	152	319	252
Days payable	73	44	47	83	64	73	31	224	122	143	251	361
Cash conversion cycle	25	32	34	17	30	39	68	157	55	95	161	−33
Working capital days	15	18	27	42	41	57	77	241	80	137	215	35
ROCE %	11.9%	26.4%	29.2%	27.7%	23.0%	9.6%	−3.6%	−25.7%	−5.9%	−25.9%	−42.6%	0.0%

Brawn Biotech: frequently asked questions

What are the latest quarterly results of Brawn Biotech?

For the Mar 2026 quarter, Brawn Biotech reported sales of ₹1.97 Cr, down 12.4% year on year and net profit of ₹0.59 Cr. The operating margin was −25.7%.

What is the annual revenue of Brawn Biotech?

Brawn Biotech's sales for the year to Mar 2026 were ₹16.94 Cr; over the last twelve months they were ₹16.94 Cr.

What is the net profit of Brawn Biotech?

Net profit for the year to Mar 2026 was ₹0.95 Cr, and ₹0.98 Cr over the last twelve months. Earnings per share over the same trailing period were ₹3.17.

How much debt does Brawn Biotech have?

Brawn Biotech reported borrowings of ₹0 Cr at Mar 2026, against cash and equivalents of ₹0.29 Cr.

What is the free cash flow of Brawn Biotech?

Cash from operations was ₹0.10 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹0.07 Cr.

Loading…